Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
9.70
-0.24 (-2.46%)
Jul 15, 2026, 12:10 PM EDT - Market open
Burning Rock Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 514.43 | 539.57 | 515.82 | 537.44 | 563.24 | 507.86 | |
Revenue Growth (YoY) | -1.69% | 4.60% | -4.02% | -4.58% | 10.90% | 18.13% |
Cost of Revenue | 130.91 | 136.65 | 153.42 | 174.21 | 183.2 | 143.72 |
Gross Profit | 383.52 | 402.91 | 362.4 | 363.23 | 380.04 | 364.15 |
Selling, General & Admin | -288.37 | -291.27 | -452.54 | -685.53 | -938.58 | -793.35 |
Research & Development | -153.66 | -166.49 | -232.29 | -347.02 | -421.87 | -367.86 |
Other Operating Expenses | - | - | -35.13 | - | - | - |
Total Operating Expenses | -442.03 | -457.76 | -719.96 | -1,033 | -1,360 | -1,161 |
Operating Income | -58.51 | -54.85 | -357.56 | -669.32 | -980.41 | -797.06 |
Interest Income | 6.73 | 8.05 | 12.21 | 17.96 | 9.36 | 3.46 |
Interest Expense | -0.05 | -0.03 | - | - | 0.1 | -1.54 |
Other Non-Operating Income (Expense) | -5.93 | -6.97 | 4.61 | 0.06 | 1.7 | -0.66 |
Total Non-Operating Income (Expense) | 0.76 | 1.06 | 16.82 | 18.02 | 11.16 | 1.27 |
Pretax Income | -57.75 | -53.79 | -340.74 | -651.3 | -969.25 | -795.8 |
Provision for Income Taxes | -1.56 | -1.56 | -5.89 | -2.39 | -1.99 | -0.9 |
Net Income | -59.32 | -55.35 | -346.63 | -653.69 | -971.23 | -796.7 |
Net Income to Common | -59.32 | -55.35 | -346.63 | -653.69 | -971.23 | -796.7 |
Shares Outstanding (Basic) | 10 | 11 | 11 | 10 | 10 | 11 |
Shares Outstanding (Diluted) | 10 | 11 | 11 | 10 | 10 | 11 |
Shares Change (YoY) | -2.81% | -2.26% | 5.05% | -0.20% | -2.35% | 0.31% |
EPS (Basic) | -5.70 | -5.20 | -33.70 | -63.80 | -93.50 | -76.50 |
EPS (Diluted) | -5.70 | -5.20 | -33.70 | -63.80 | -93.50 | -76.50 |
Free Cash Flow | -34.22 | -33.69 | -97.68 | -263.89 | -527.1 | -688.81 |
Free Cash Flow Per Share | -3.35 | -3.20 | -9.08 | -25.76 | -51.35 | -65.53 |
Gross Margin | 74.55% | 74.67% | 70.26% | 67.59% | 67.47% | 71.70% |
Operating Margin | -11.37% | -10.16% | -69.32% | -124.54% | -174.07% | -156.94% |
Profit Margin | -11.53% | -10.26% | -67.20% | -121.63% | -172.44% | -156.87% |
FCF Margin | -6.65% | -6.24% | -18.94% | -49.10% | -93.58% | -135.63% |
EBITDA | -58.51 | -33.08 | -305.36 | -535.92 | -856.31 | -749.3 |
EBITDA Margin | -11.37% | -6.13% | -59.20% | -99.72% | -152.03% | -147.54% |
EBIT | -58.51 | -54.85 | -357.56 | -669.32 | -980.41 | -797.06 |
EBIT Margin | -11.37% | -10.16% | -69.32% | -124.54% | -174.07% | -156.94% |
Effective Tax Rate | 2.71% | 2.89% | 1.73% | 0.37% | 0.20% | 0.11% |